The correlation between ALKBH5 mRNA expression levels and the prognosis of patients with primary glioma, recurrent glioma, low grade glioma (LGG) or glioblastoma (GBM) was investigated using the CGGA and TCGA datasets. Here, ALKBH5 is linked to central nervous system cancer.